Smith, A
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
Abnormal lipid metabolism with oxidative stress, ferroptosis and T cell dysfunction Previous studies on a small number of patients have reported conflicting results regarding the association between vitiligo and dyslipidemia
Diet soda Diet soft drinks contain artificial sweeteners instead of sugar
In the STEP 1 trial, participants who reached and maintained this dose level showed meaningful weight loss over the study period
These questions matter more than whether you are losing weight as fast as a stranger on the internet